Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort

BACKGROUND: We reported a significant 67% reduction in the hazard risk of incident Alzheimer's disease (AD) with elective statin use in the AD Anti-inflammatory Prevention Trial (ADAPT), without a reduction in risk of incident mild cognitive impairment (MCI). OBJECTIVE: To assess if cholesterol...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sparks, D. Larry, Kryscio, Richard J., Connor, Donald J., Sabbagh, Marwan N., Sparks, Lisa M., Lin, Yushun, Liebsack, Carolyn
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2010
Teme:
Treatment and Prevention
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2859238/
https://ncbi.nlm.nih.gov/pubmed/20224282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000295660
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki